December 11, 2012—Invest'in Photonics 2012, a 2-day convention in Bordeaux, France, will partner venture capital investors looking for opportunity with 18 pre-screened innovative European companies offering leading-edge photonics applications in cleantech, healthcare and consumer goods.
The third bienniel event, to be held December 12-13, will include a special funding session that enables companies to present their technology to a panel of investors to compete for up to US$90 million (€72.2 million) in investment funds. The Bordeaux region of France is a growing industrial center for lasers, optics and photonics.
Invest'in Photonics is a unique event in Europe, designed to bring investors in search of the most innovative, credible and profitable business ventures in photonics together with photonics firms. The photonics industry is a US$388 billion (€300 billion) market.
An international panel of photonics industry veterans and venture capitalists selected the targeted companies based on their technology uniqueness, business model, market strategy, potential market size, management experience/scalability, and opportunity for international development.
Companies selected for the special funding session include ActLight (Switzerland), Argolight (France), Aurea Technology (France), Blue Industry & Science (France), Fibercryst (France), Holixica (United Kingdom), Image Guided Therapy (France), Lasar France), Mach8 Lasers (the Netherlands), Med-Imaps (France), µQUANS (France), Nethis (France), Ovizio Imaging Systems (Belgium), Prestodiag (France), Smart Photonics (the Netherlands), Sunna Design (France), Vence Innovation (France) plus one unnamed firm.
The biennial event has helped raise €37 million total from the first two events in 2008 and 2010.